Loading institutional data...
Loading institutional data...
Held by 167 of 5,944 reporting institutions (90th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
1/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$179M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2024 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
No current price collected.
Nothing notable to watch.
Where each multiple sits in its own 5-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| R&D | 177.7 | 208.4 | 366.3 | 220.4 | 230.9 | 186.8 | 143.3 |
| SG&A | 54.4 | 50.0 | 275.0 | 299.3 | 153.1 | 108.4 | 107.7 |
| Operating Income | -132.1 | -178.8 | -582.6 | -462.4 | -343.8 | -246.5 | -185.3 |
| Income Tax | 0.0 | 2.5 | -0.5 | -3.1 | -0.0 | -0.2 | -0.5 |
| Net Income | -220.2 | -165.2 | -0.6 | -0.4 | -0.4 | -0.2 | -0.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on DNA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $170.2M 100.0% | $227.0M 100.0% | $251.5M 100.0% | $477.7M 100.0% | $313.8M 100.0% | $76.7M 100.0% | $54.2M 100.0% |
| Research & Development | $243.8M 143.3% | $424.1M 186.8% | $580.6M 230.9% | $1.05B 220.4% | $1.15B 366.3% | $159.8M 208.4% | $96.3M 177.7% |
| Selling, General & Admin | $183.3M 107.7% | $246.2M 108.4% | $385.0M 153.1% | $1.43B 299.3% | $863.0M 275.0% | $38.3M 50.0% | $29.5M 54.4% |
| Total Operating Expenses | $485.4M 285.3% | $786.8M 346.5% | $1.12B 443.8% | $2.69B 562.4% | $2.14B 682.6% | $213.7M 278.8% | $125.8M 232.1% |
| Operating Income | -$315.3M -185.3% | -$559.8M -246.5% | -$864.4M -343.8% | -$2.21B -462.4% | -$1.83B -582.6% | -$137.0M -178.8% | -$71.6M -132.1% |
| Interest Expense | $0 0.0% | $94K 0.0% | $93K 0.0% | $106K 0.0% | $2.4M 0.8% | $2.4M 3.1% | $2.4M 4.5% |
| Interest & Investment Income | $22.6M 13.3% | $38.6M 17.0% | $57.2M 22.8% | $20.3M 4.2% | $837K 0.3% | $2.6M 3.4% | $5.8M 10.6% |
| Other Income (Expense), net | $1.7M 1.0% | $12.2M 5.4% | -$28.5M -11.3% | $87.6M 18.3% | -$9.7M -3.1% | $12.2M 15.9% | — |
| Pretax Income | -$313.6M -184.3% | -$547.5M -241.1% | -$892.9M -355.1% | -$2.12B -444.1% | -$1.84B -585.7% | -$124.8M -162.8% | -$119.8M -221.2% |
| Income Tax Expense | -$837K -0.5% | -$479K -0.2% | -$71K -0.0% | -$15.0M -3.1% | -$1.5M -0.5% | $1.9M 2.5% | $22K 0.0% |
| Net Income | -$313K -0.2% | -$547K -0.2% | -$893K -0.4% | -$2.1M -0.4% | -$1.8M -0.6% | -$126.6M -165.2% | -$119.3M -220.2% |
| Per Share | |||||||
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 |
| Weighted Avg Shares (Basic) | 55.5M | 51.9M | 48.6M | 42.0M | 1.36B | 1.27B | 1.15B |
| Weighted Avg Shares (Diluted) | 55.5M | 51.9M | 48.6M | 42.0M | 1.36B | 1.27B | 1.15B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position